Feedback

American company states about success of the first trial of vaccine against Covid-19

Source : 112 Ukraine

Moderna considers the vaccine to be safe and well-tolerated
15:20, 19 May 2020

Open source

The U.S. Company Moderna Inc states about the success of the first trials of the vaccine against Covid-19 coronavirus disease, as Moderna reported.

Thus, the experimental vaccine mRNA-1273 at the early stage of the clinical trials developed antibodies capable of neutralized SARS-CoV-2 coronavirus in the body of a human.

Moderna considers the vaccine to be safe and well-tolerated.

Related: 62 Ukrainians recover from Covid-19 abroad

During the second phase of the trials, the researches will examine the influence of 50mg and 100 mg of the vaccine on the body. The third phase is planned for July 2020.

The company has started the clinical trials of the experimental vaccine against Covid-19 in March.

As we reported, the US biopharmaceutical company claims to have discovered an antibody that could shield the human body from the coronavirus and flush it out of a person’s system within four days. Sorrento Therapeutics will announce their discovery of the STI-1499 antibody, which the San Diego company said can provide "100% inhibition" of COVID-19, adding that a treatment could be available months before a vaccine hits the market.

 

 

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more